08/18/2025
5:54 AM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2025
8:00 PM | Abingworth Bioventures VII LP (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2025
3:35 PM | Nantahala Capital Management, LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
08/14/2025
10:16 AM | JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
08/14/2025
6:13 AM | Avoro Capital Advisors LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
08/12/2025
7:52 PM | Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
08/12/2025
8:05 AM | Adage Capital Management, L.P. (Filed by)
Soleno Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
08/07/2025
9:17 AM | FMR LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
08/06/2025
4:16 PM | Soleno Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2025
11:14 AM | FMR LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SCHEDULE 13G | |
07/17/2025
7:12 PM | BlackRock, Inc. (Filed by)
Soleno Therapeutics (Subject)
| Form SCHEDULE 13G | |
Get the Latest News and Ratings for SLNO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Soleno Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
07/10/2025
8:43 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2025
8:45 PM | Soleno Therapeutics (Filer)
| Form 424B5 | |
07/10/2025
5:05 AM | Soleno Therapeutics (Filer)
| Form 424B5 | |
07/10/2025
5:10 AM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2025
3:41 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
5:04 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
6:19 PM | Bir Dawn Carter (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
6:20 PM | Harris William G (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
6:21 PM | Pauls Matthew (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
6:25 PM | Sinclair Andrew (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
6:27 PM | Soleno Therapeutics (Issuer)
Volck Birgitte (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
11:02 AM | JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/14/2025
9:45 AM | PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Soleno Therapeutics (Subject)
| Form SCHEDULE 13G | |
05/12/2025
8:06 AM | Adage Capital Management, L.P. (Filed by)
Soleno Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/30/2025
4:15 PM | Nantahala Capital Management, LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/22/2025
3:49 PM | Soleno Therapeutics (Filer)
| Form DEF 14A | |
04/22/2025
3:52 PM | Soleno Therapeutics (Filer)
| Form DEFA14A | |
04/22/2025
3:54 PM | Soleno Therapeutics (Filer)
| Form ARS | |
04/02/2025
4:38 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/31/2025
7:00 PM | Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
03/31/2025
6:18 PM | Huang Michael F. (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/31/2025
6:20 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/31/2025
6:21 PM | Manning Meredith (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/31/2025
6:23 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/31/2025
6:24 PM | Pauls Matthew (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/31/2025
6:00 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/31/2025
6:01 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
6:03 PM | Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
11:45 AM | Pauls Matthew (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2025
7:53 AM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
"I'm risking my reputation on this" (Ad) A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year.
That's why we've rushed to update our book "Crypto Revolution" – to show you exactly how to position yourself for this historic opportunity. Click here to claim your FREE copy now! |
03/27/2025
7:54 AM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2025
7:55 AM | Huang Michael F. (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2025
7:55 AM | Mackaness James H (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2025
7:56 AM | Manning Meredith (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2025
7:57 AM | Soleno Therapeutics (Subject)
Yen Kristen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2025
4:00 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2025
3:31 PM | Soleno Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2025
8:22 AM | Soleno Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
3:30 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
10:56 AM | JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
8:34 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Soleno Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/05/2025
4:28 PM | BlackRock, Inc. (Filed by)
Soleno Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/23/2025
3:22 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:24 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:25 PM | Huang Michael F. (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:27 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:28 PM | Manning Meredith (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:29 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
8:55 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
8:56 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
8:56 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
8:57 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:30 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
7:46 AM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2024
8:44 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
11/14/2024
3:53 PM | Nantahala Capital Management, LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
11/14/2024
8:36 AM | Avoro Capital Advisors LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
11/12/2024
8:33 AM | Adage Capital Management, L.P. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G/A | |
11/06/2024
3:06 PM | Soleno Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/24/2024
3:44 PM | BlackRock, Inc. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
10/21/2024
3:30 PM | Abingworth Bioventures VII LP (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024
3:31 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
10/15/2024
3:31 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
10/10/2024
3:30 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
10/03/2024
4:53 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
4:55 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
5:02 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
5:03 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
8:55 AM | JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
09/10/2024
5:30 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
09/05/2024
5:37 PM | Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G | |
08/30/2024
5:33 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
5:34 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
5:35 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
5:36 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
6:36 PM | Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
6:14 PM | Soleno Therapeutics (Issuer)
Urbanski Raymond W. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/23/2024
6:16 PM | Soleno Therapeutics (Issuer)
Urbanski Raymond W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
MarketBeat All Access